Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

OBJECTIVE: Initial presentations of psychosis require a thorough physical health assessment to identify comorbidities, establish treatment safety and exclude organic causes of psychosis. Despite clinical consensus that these assessments are essential, global guidelines are variable and outdated. This work aimed to synthesise current evidence to inform updated recommendations for physical assessments in psychosis, balancing thorough investigation with practical applicability. METHODS: A scoping review of physical health disorders associated with psychosis was conducted using PubMed, Embase and CINAHL. Separately, a systematic review of international guidelines from 2000 to 2025 was performed, extracting physical health assessment recommendations for schizophrenia spectrum disorders. A narrative analysis evaluated the clinical utility of identified investigations. RESULTS: Eighty-four physical health disorders with potential psychotic presentations were identified, mostly rare and typically associated with other neurological or systemic features. There was significant heterogeneity in investigations advised by the 25 identified guidelines, outside of the common consideration for metabolic screening. The majority of guidelines considered investigations for both the exclusion of organic causes of psychosis and identifying a physical health baseline or comorbidity. There was limited consistency around recommendations for neuroimaging or autoimmune screening. Clinical assessment remains central to determining appropriate investigations. CONCLUSION: Global inconsistency in assessment recommendations reflects the complexity of distinguishing organic psychoses from primary psychiatric disorders. Structured yet individualised assessments, informed by symptomatology and risk factors, are essential. A staged, context-sensitive approach is proposed to optimise diagnostic accuracy and avoid unnecessary testing. Updated, evidence-informed guidelines are critical for improving care for people with psychosis.

Authors

Institutions

Publication Details

Journal
Australian & New Zealand Journal of Psychiatry
Published
2026-04-26
DOI
https://doi.org/10.1177/00048674261435740
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

Dan J. Siskind, Sean Halstead, Naomi Runnegar, Toby Pillinger et al.
Australian & New Zealand Journal of Psychiatry
Schizophrenia research and treatment
article

Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations

Dan J. Siskind, Sean Halstead, Naomi Runnegar, Toby Pillinger, Graham Blackman, Frances Louise Dark, Julia Lappin, Susanna Every‐Palmer, Cullen O'gorman, Nicole Korman, Nicola Warren, Sharon Lawn, Robert A. McCutcheon, James G. Scott, Samantha M. Loi, Shuichi Suetani, Thomas Skerlj, Brian O’Donoghue, Andrew Thompson, Jessemin Firman
article en

Abstract

OBJECTIVE: Initial presentations of psychosis require a thorough physical health assessment to identify comorbidities, establish treatment safety and exclude organic causes of psychosis. Despite clinical consensus that these assessments are essential, global guidelines are variable and outdated. This work aimed to synthesise current evidence to inform updated recommendations for physical assessments in psychosis, balancing thorough investigation with practical applicability. METHODS: A scoping review of physical health disorders associated with psychosis was conducted using PubMed, Embase and CINAHL. Separately, a systematic review of international guidelines from 2000 to 2025 was performed, extracting physical health assessment recommendations for schizophrenia spectrum disorders. A narrative analysis evaluated the clinical utility of identified investigations. RESULTS: Eighty-four physical health disorders with potential psychotic presentations were identified, mostly rare and typically associated with other neurological or systemic features. There was significant heterogeneity in investigations advised by the 25 identified guidelines, outside of the common consideration for metabolic screening. The majority of guidelines considered investigations for both the exclusion of organic causes of psychosis and identifying a physical health baseline or comorbidity. There was limited consistency around recommendations for neuroimaging or autoimmune screening. Clinical assessment remains central to determining appropriate investigations. CONCLUSION: Global inconsistency in assessment recommendations reflects the complexity of distinguishing organic psychoses from primary psychiatric disorders. Structured yet individualised assessments, informed by symptomatology and risk factors, are essential. A staged, context-sensitive approach is proposed to optimise diagnostic accuracy and avoid unnecessary testing. Updated, evidence-informed guidelines are critical for improving care for people with psychosis.

Australian & New Zealand Journal of Psychiatry
University College Dublin (IE), The Royal Melbourne Hospital (AU), The University of Queensland (AU), The University of Melbourne (AU), Flinders University (AU), King's College London (GB), South London and Maudsley NHS Foundation Trust (GB), Princess Alexandra Hospital (AU), Oxford Health NHS Foundation Trust (GB), UNSW Sydney (AU), University of Oxford (GB), Metro South Health (AU), Children’s Health Queensland Hospital and Health Service (AU), Queensland Centre for Mental Health Research (AU), Orygen (AU), St. Vincent's University Hospital (IE), Institute for Urban Indigenous Health (AU), University of Otago (NZ)
Brain and Behavior Research Foundation, Wellcome Trust, Maudsley Charity, Australian Government, National Institute for Health and Care Research, Royal Australian and New Zealand College of Psychiatrists, National Health and Medical Research Council
Openalex Percentile: Top 11%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.